Review the details below, then apply to join this clinical trial.
At a Glance
Age
25 – 50
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Austin V Stone · Other
Who this trial is looking for
This trial is looking for patients who are having knee surgery for an ACL injury and have a meniscus tear. Participants will take a daily pill called montelukast or a placebo for 6 months after their surgery.
Are You a Good Fit for This Trial?
You may be able to join if
I am undergoing primary ACL reconstruction
I am between 25 and 50 years old
I have a meniscus injury
You may not be able to join if
I am undergoing a revision procedure
I have multiple ligament injuries requiring reconstruction
I have depressive symptoms or suicidal thoughts
I do not have a meniscus tear at the time of surgery
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This is a multicenter randomized, placebo-controlled trial to assess whether a 6-month course of oral montelukast after ACL reconstruction reduces systemic markers of inflammation and biochemical and imaging biomarkers of cartilage degradation. This study will specifically target older ACL reconstruction patients with concomitant meniscal injuries as this group is at greatest risk of rapid PTOA pr…
This is a multicenter randomized, placebo-controlled trial to assess whether a 6-month course of oral montelukast after ACL reconstruction reduces systemic markers of inflammation and biochemical and imaging biomarkers of cartilage degradation. This study will specifically target older ACL reconstruction patients with concomitant meniscal injuries as this group is at greatest risk of rapid PTOA progression. Patients will randomly be assigned to receive oral montelukast (10 mg) versus placebo daily for 6 months after surgery.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
1. Undergoing primary ACL reconstruction
2. Age between 25-50
3. Concomitant meniscus injury
Exclusion Criteria:
1. Undergoing revision procedures
2. Multiple ligament injuries requiring multiple ligament reconstruction/repair
3. Depressive symptoms and/or those who endorse su…
Inclusion Criteria:
1. Undergoing primary ACL reconstruction
2. Age between 25-50
3. Concomitant meniscus injury
Exclusion Criteria:
1. Undergoing revision procedures
2. Multiple ligament injuries requiring multiple ligament reconstruction/repair
3. Depressive symptoms and/or those who endorse suicidal ideation at the time of enrollment (PHQ-9 score \>= 15)
4. Found to not have a meniscus tear at the time of surgery
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.